These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 10914565)

  • 1. A Case of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with Coexistence of the
    Han LL; Yang X; Dai H; Zhu J
    Turk J Haematol; 2024 May; 41(2):123-125. PubMed ID: 38528751
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular and phenotypic spectrum of de novo Philadelphia positive acute leukemia.
    Lim LC; Heng KK; Vellupillai M; Tan LT; Boey BC; Lau LC; How GF
    Int J Mol Med; 1999 Dec; 4(6):665-7. PubMed ID: 10567681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity in lineage derivation of Philadelphia-positive acute lymphoblastic leukemia expressing p190BCR-ABL or p210BCR-ABL: determination by analysis of individual colonies with the polymerase chain reaction.
    Estrov Z; Talpaz M; Kantarjian HM; Zipf TF; McClain KL; Kurzrock R
    Cancer Res; 1993 Jul; 53(14):3289-93. PubMed ID: 8324740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of E6A2 BCR-ABL fusion in a Philadelphia-positive CML.
    Dupont M; Jourdan E; Chiesa J
    Leukemia; 2000 Nov; 14(11):2011-2. PubMed ID: 11069039
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of tumor-specific antigens in Philadelphia chromosome positive leukemias.
    van Denderen J; ten Hacken P; Berendes P; van Ewijk W
    Leuk Lymphoma; 1993; 11 Suppl 1():29-32. PubMed ID: 7504546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of micromegakaryocytes in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Kobayashi S; Maruta A; Yamamoto T; Fujisawa S; Fukawa H; Kanamori H; Matsuzaki M; Motomura S; Kodama F; Ishigatsubo Y
    Leukemia; 2000 Jul; 14(7):1327-9. PubMed ID: 10914565
    [No Abstract]   [Full Text] [Related]  

  • 7. Differences between blastic chronic myeloid leukemia and Ph-positive acute leukemia.
    Berger R
    Leuk Lymphoma; 1993; 11 Suppl 1():235-7. PubMed ID: 8251902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic granulocytic leukemia (Ph+): among yesterday's myeloproliferative syndromes, today's chronic myeloid leukemias, and tomorrow's mature-element monocellular myelopathies].
    Sánchez Fayos J; Prieto E; Chica Gullón E
    Sangre (Barc); 1998 Apr; 43(2):121-6. PubMed ID: 9656773
    [No Abstract]   [Full Text] [Related]  

  • 9. Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia.
    Drexler HG; MacLeod RA; Uphoff CC
    Leuk Res; 1999 Mar; 23(3):207-15. PubMed ID: 10071072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary Philadelphia chromosome in a patient with acute lymphoblastic leukemia.
    Chen L; Stamatoullas A; Bastard C; Tilly H
    Cancer Genet Cytogenet; 2004 Jul; 152(2):132-5. PubMed ID: 15262432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular measurement of minimal residual disease in Philadelphia-positive acute lymphoblastic leukaemia.
    Radich JP
    Best Pract Res Clin Haematol; 2002 Mar; 15(1):91-103. PubMed ID: 11987918
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.